Clinical Trial Update: Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether prophylactic moxifloxacin after high-dose chemotherapy with peripheral stem cell transplantation reduces bacteremia in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Avelox (moxifloxacin)

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin Disease, Non-Hodgkin Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2013-12-11